Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC raised its stake in Inogen, Inc. (NASDAQ:INGN) by 17.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 492,900 shares of the medical technology company’s stock after purchasing an additional 75,000 shares during the quarter. Renaissance Technologies LLC’s holdings in Inogen were worth $4,520,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Invesco Ltd. boosted its holdings in Inogen by 2.0% in the fourth quarter. Invesco Ltd. now owns 78,142 shares of the medical technology company’s stock valued at $717,000 after acquiring an additional 1,545 shares during the last quarter. Federated Hermes Inc. lifted its stake in shares of Inogen by 16.8% in the 4th quarter. Federated Hermes Inc. now owns 404,273 shares of the medical technology company’s stock valued at $3,707,000 after purchasing an additional 58,257 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its holdings in shares of Inogen by 66.4% during the 4th quarter. Dynamic Technology Lab Private Ltd now owns 33,770 shares of the medical technology company’s stock worth $310,000 after purchasing an additional 13,474 shares during the period. Wells Fargo & Company MN increased its position in Inogen by 27.8% during the 4th quarter. Wells Fargo & Company MN now owns 13,917 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 3,031 shares in the last quarter. Finally, Integrated Quantitative Investments LLC purchased a new position in Inogen in the fourth quarter valued at approximately $92,000. 89.94% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on INGN. Needham & Company LLC restated a “hold” rating on shares of Inogen in a report on Wednesday, April 9th. StockNews.com lowered shares of Inogen from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th.

Inogen Trading Down 1.2 %

Shares of INGN opened at $6.74 on Tuesday. The firm has a market cap of $181.22 million, a price-to-earnings ratio of -3.00 and a beta of 1.48. Inogen, Inc. has a 52 week low of $6.40 and a 52 week high of $13.33. The stock has a 50 day moving average of $7.88 and a 200-day moving average of $9.12.

About Inogen

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.